Not_yet_recruitingNCT07586098

Artificial Intelligence for the Automated Diagnosis, Triage, and Assessment of Patients With Hearing Loss and Tinnitus: A Pilot Comparative Study With Clinical Evaluation by Otolaryngologists

Sponsor: Royal Cornwall Hospitals Trust

Trial Details

Condition	Hearing Loss, Adult-Onset, Tinnitus
Intervention	Artificial Intelligence (AI) Assisted Clinical Decision Support Tool for managing Hearing Loss and Tinnitus
Status	Not_yet_recruiting
Participants	1,500
Est. Completion	13 Aug 2026
Last Updated	14 May 2026

Primary Outcome

MRI internal auditory meatus (IAM) referral recommendation; Clinical triage outcome

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Patients assessed in the RCHT virtual hearing loss and tinnitus clinic. * Presenting symptoms of hearing loss and/or tinnitus. * Ability to provide informed consent to participate in the study. Exclusion Criteria: * Individuals under 18 years of age. * Patients unable to provide informed consent. * Patients without sufficient English proficiency where translation services cannot be arranged. * Cases where data quality is insufficient for analysis.

Trial Sites

Countries

United Kingdom

View Registry Entry

Related Analysis

UK Pilot Trial Tests AI-Assisted Triage for Hearing Loss and Tinnitus — Implications for Australian ENT Services

UK researchers are testing an AI-assisted clinical decision support tool for hearing loss and tinnitus triage in virtual ENT clinics. The 1,500-patient pilot study could transform how otolaryngology services manage capacity constraints and reduce waiting times.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service